Croda International Plc has announced the acquisition of IRB (Istituto di Ricerche Biotecnologiche SpA).
IRB entered the active ingredients market in 2009 after 10 years of research and as a result of its cutting edge technology and ‘know how’, it has become a leader in the emerging market of plant cell culture actives both in personal care and healthcare. A Croda spokesperson said: “This is an exciting acquisition for Croda and the personal care industry. Croda, via the Sederma brand will use our knowledge, expertise and global positioning to bring IRB’s world leading plant cell culture technology to all of our customers. Plant cell culture biotechnology is the leading new technology for delivering proven activity as well as true sustainability.” The IRB products will add to the Sederma product portfolio, already widely acclaimed for their peptide anti-ageing ingredients as well as other bioactive molecules. IRB will benefit from significant investment as part of the Croda group.
